125 related articles for article (PubMed ID: 16515288)
1. [Monthly tablet in postmenopausal osteoporosis].
Krankenpfl J; 2005; 43(7-10):216. PubMed ID: 16515288
[No Abstract] [Full Text] [Related]
2. Treatment holidays in patients with postmenopausal osteoporosis: whom and when?
Reyes García R; García Martín A; Muñoz-Torres M
Endocrinol Nutr; 2012 Dec; 59(10):573-4. PubMed ID: 23031434
[No Abstract] [Full Text] [Related]
3. Is it feasible to adjust bisphosphonate dose according to bone mineral density value in postmenopausal breast cancer patients with bone metastases?
Delibasi T; Akkus NI; Altundag O; Pinar T; Altundag K
Med Hypotheses; 2006; 66(6):1254-5. PubMed ID: 16413688
[No Abstract] [Full Text] [Related]
4. [Treating with what? Therapy for how long?].
MMW Fortschr Med; 2005 Dec; 147(51-52):62-3. PubMed ID: 16402713
[No Abstract] [Full Text] [Related]
5. Intravenous ibandronate (Boniva).
Med Lett Drugs Ther; 2006 Aug 14-28; 48(1241-1242):68-9. PubMed ID: 16977282
[No Abstract] [Full Text] [Related]
6. Lasofoxifene: new drug. Osteoporosis: no better than raloxifene.
Prescrire Int; 2009 Dec; 18(104):247. PubMed ID: 20020572
[No Abstract] [Full Text] [Related]
7. Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study.
Eisman JA; Civitelli R; Adami S; Czerwinski E; Recknor C; Prince R; Reginster JY; Zaidi M; Felsenberg D; Hughes C; Mairon N; Masanauskaite D; Reid DM; Delmas PD; Recker RR
J Rheumatol; 2008 Mar; 35(3):488-97. PubMed ID: 18260172
[TBL] [Abstract][Full Text] [Related]
8. [Postmenopausal osteoporosis].
Krankenpfl J; 2005; 43(4-6):150. PubMed ID: 16171093
[No Abstract] [Full Text] [Related]
9. [Calcium pros and cons: long term use of bisphosphonates. Bisphosphonates should be used for postmenopausal osteoporosis for a long term].
Soen S
Clin Calcium; 2011 Oct; 21(10):1543-6. PubMed ID: 21960242
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates: when and for whom?
Reid DM
J Br Menopause Soc; 2003 Dec; 9(4):145, 155. PubMed ID: 15107255
[No Abstract] [Full Text] [Related]
11. [Ibandronate once a month].
Polk B
Med Monatsschr Pharm; 2006 Jan; 29(1):36-7. PubMed ID: 16463553
[No Abstract] [Full Text] [Related]
12. A once-yearly IV bisphosphonate for osteoporosis.
Med Lett Drugs Ther; 2007 Nov; 49(1273):89-90. PubMed ID: 17975523
[No Abstract] [Full Text] [Related]
13. Once-monthly dosing: an effective step forward.
Reid DM
Bone; 2006 Apr; 38(4 Suppl 1):S18-22. PubMed ID: 16533625
[TBL] [Abstract][Full Text] [Related]
14. Yearly zoledronic acid in postmenopausal osteoporosis.
Najib MA; Aziz I
N Engl J Med; 2007 Aug; 357(7):713; author reply 714-5. PubMed ID: 17703527
[No Abstract] [Full Text] [Related]
15. Use of bisphosphonates in the management of postmenopausal osteoporosis.
Papapoulos SE
Ann N Y Acad Sci; 2011 Feb; 1218():15-32. PubMed ID: 20946579
[TBL] [Abstract][Full Text] [Related]
16. [Osteoporosis-induced fractures. Bisphosphonates lower risk also in the hip].
MMW Fortschr Med; 2000 Jul; 142(30):52-3. PubMed ID: 10955025
[No Abstract] [Full Text] [Related]
17. Change in arterial stiffness associated with monthly bisphosphonate treatment in women with postmenopausal osteoporosis.
Igase M; Kohara K; Tabara Y; Ohara M; Takita R; Ochi M; Okada Y; Miki T
Menopause; 2014 Sep; 21(9):962-6. PubMed ID: 24552979
[TBL] [Abstract][Full Text] [Related]
18. The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal women.
Grey A; Bolland MJ; Wattie D; Horne A; Gamble G; Reid IR
J Clin Endocrinol Metab; 2009 Feb; 94(2):538-44. PubMed ID: 19050050
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates: a once-yearly treatment option with Reclast.
Van Gilder D
S D Med; 2008 Nov; 61(11):416-7. PubMed ID: 19066136
[No Abstract] [Full Text] [Related]
20. Treatments for osteoporosis - looking beyond the HORIZON.
Compston J
N Engl J Med; 2007 May; 356(18):1878-80. PubMed ID: 17476015
[No Abstract] [Full Text] [Related]
[Next] [New Search]
